abstract |
The present invention provides compounds of the Formula I and II, wherein R?1¨, R?3¨, W, Z, X?1¨, X?2¨, Ar?1¨, R?8¨ and R?9¨ are as defined herein, processes and intermediates for their preparation and their use for the treatment of p38 mediated disorders. |